Clinical Trial Update: Paclitaxel and Carboplatin Combination as 1st Line Treatment in Ovarian Carcinomas [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update on paclitaxel and carboplatin as first-line treatment for ovarian cancer; the Phase 1/2 study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Hellenic Oncology Research Group | Conditions: Ovarian Cancer | Phase 1, Phase 2 | Status: COMPLETED